BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33735885)

  • 1. Stress Hormones as Predictors of Response to Cognitive Behavior Therapy in Panic Disorder.
    Masdrakis VG; Legaki EM; Papageorgiou C; Markianos M
    Neuropsychobiology; 2021; 80(5):401-410. PubMed ID: 33735885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the cortisol stress response on the psychotherapy outcome of panic disorder patients.
    Wichmann S; Kirschbaum C; Lorenz T; Petrowski K
    Psychoneuroendocrinology; 2017 Mar; 77():9-17. PubMed ID: 27987430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of plasma oxytocin with clinical and hormonal parameters in panic disorder.
    Masdrakis VG; Papageorgiou C; Markianos M
    Nord J Psychiatry; 2023 Apr; 77(3):221-226. PubMed ID: 35714973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-adrenal axis hormones in early-onset versus late-onset panic disorder.
    Masdrakis VG; Legaki EM; Papageorgiou C; Markianos M
    Int J Psychiatry Clin Pract; 2022 Mar; 26(1):72-78. PubMed ID: 33043745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia.
    Wichmann S; Bornstein SR; Lorenz T; Petrowski K
    Transl Psychiatry; 2018 Feb; 8(1):37. PubMed ID: 29391399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline heartbeat perception accuracy and short-term outcome of brief cognitive-behaviour therapy for panic disorder with agoraphobia.
    Masdrakis VG; Legaki EM; Vaidakis N; Ploumpidis D; Soldatos CR; Papageorgiou C; Papadimitriou GN; Oulis P
    Behav Cogn Psychother; 2015 Jul; 43(4):426-35. PubMed ID: 24330918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fear of Fear and Broad Dimensions of Psychopathology over the Course of Cognitive Behavioural Therapy for Panic Disorder with Agoraphobia in Japan.
    Ogawa S; Kondo M; Ino K; Ii T; Imai R; Furukawa TA; Akechi T
    East Asian Arch Psychiatry; 2017 Dec; 27(4):150-5. PubMed ID: 29259145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
    Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
    BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Running for extinction? Aerobic exercise as an augmentation of exposure therapy in panic disorder with agoraphobia.
    Bischoff S; Wieder G; Einsle F; Petzold MB; Janßen C; Mumm JLM; Wittchen HU; Fydrich T; Plag J; Ströhle A
    J Psychiatr Res; 2018 Jun; 101():34-41. PubMed ID: 29539585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
    Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
    Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder.
    Gulpers B; Oude Voshaar R; Kampman M; Verhey F; VAN Alphen S; Hendriks GJ
    J Psychiatr Pract; 2020 May; 26(3):164-174. PubMed ID: 32421288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
    Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
    Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
    Vos SP; Huibers MJ; Diels L; Arntz A
    Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychoticism in patients with panic disorder with or without comorbid agoraphobia.
    Masdrakis VG; Legaki EM; Papageorgiou C; Markianos M
    Int J Psychiatry Clin Pract; 2017 Sep; 21(3):181-187. PubMed ID: 28345374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioral therapy for panic disorder with agoraphobia in older people: a comparison with younger patients.
    Hendriks GJ; Kampman M; Keijsers GP; Hoogduin CA; Voshaar RC
    Depress Anxiety; 2014 Aug; 31(8):669-77. PubMed ID: 24867666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
    Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
    J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia.
    Lueken U; Straube B; Konrad C; Wittchen HU; Ströhle A; Wittmann A; Pfleiderer B; Uhlmann C; Arolt V; Jansen A; Kircher T
    Am J Psychiatry; 2013 Nov; 170(11):1345-55. PubMed ID: 23982225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia.
    Siegmund A; Köster L; Meves AM; Plag J; Stoy M; Ströhle A
    J Psychiatr Res; 2011 Mar; 45(3):339-46. PubMed ID: 20673917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.
    Gottschalk MG; Richter J; Ziegler C; Schiele MA; Mann J; Geiger MJ; Schartner C; Homola GA; Alpers GW; Büchel C; Fehm L; Fydrich T; Gerlach AL; Gloster AT; Helbig-Lang S; Kalisch R; Kircher T; Lang T; Lonsdorf TB; Pané-Farré CA; Ströhle A; Weber H; Zwanzger P; Arolt V; Romanos M; Wittchen HU; Hamm A; Pauli P; Reif A; Deckert J; Neufang S; Höfler M; Domschke K
    Transl Psychiatry; 2019 Feb; 9(1):75. PubMed ID: 30718541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia.
    Porter E; Chambless DL
    Clin Psychol Rev; 2015 Dec; 42():179-92. PubMed ID: 26443228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.